Acute Porphyria Drug Database

Monograph

B05AA05 - Dextran
Not porphyrinogenic
NP

Rationale
Polysaccharide. No CYP-interactions.
Chemical description
Dextran, plasma substitute

Similar drugs
Explore alternative drugs in similar therapeutic classes B05A / B05AA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
United Kingdom
Dextran '40' · Dextran '40' 10% in Glucose 5% solution for injection 500ml bags · Dextran '40' 10% in Sodium chloride 0.9% solution for injection 500ml bags · Dextran '70' · Dextran '70' 6% in Glucose 5% solution for injection 500ml bags · Dextran '70' 6% in sodium chloride 0.9% solution for injection 500ml bags · RescueFlow · RescueFlow 6% infusion 250ml bags
Denmark
Rescueflow
Norway
RescueFlow
Poland
10% Dekstran 40 000 Fresenius
Iceland
RescueFlow
Finland
Rescueflow
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙